See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.75▲ 1.85%
← NEL page
XStocksXray
Market X-Ray report · 27 October 2026

Nel ASA (NEL)

Oslo Børs · Norway · prices in NOK · close of 27 Oct 2026

Key indicators

Last closeNOK 1.970
52-week range1.919 – 3.955
Return, 1 month / 3 months−4.4% / −7.5%
Return, 1 year / 3 years−14.9% / −70.1%
TrendBelow its 200-day average
RSI (14)43
Volatility (1 year)59.0%
Worst drawdown (1 year)-49.0%
Average daily value traded4.87M NOK
Dividend yield–

Market X-Ray price-based

29/ 100 · High confidence · ahead of 20% of stocks on this exchange
Trend19
Momentum27
Stability (higher is calmer)22
Liquidity61
Income–

Five-year price chart navy: price · brown: 200-day average

0.965.6310.3014.9719.632021-102023-012024-042025-072026-10

About the company

Nel ASA is a Norwegian hydrogen technology company based in Oslo. It develops and manufactures electrolysers, equipment that uses electricity to split water into hydrogen and oxygen, and it supplies hydrogen fuelling stations and related equipment for refuelling vehicles. Its customers include industrial companies, energy firms and operators of hydrogen filling stations, and its products serve markets working on hydrogen production and distribution for transport and industry.

The shares are listed on the Oslo Børs in Norway under the code NEL, and the price on this page is in Norwegian kroner (NOK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Nel ASA (NEL) trades on the Oslo Børs in Norway. It last closed at NOK 1.970 on 27 October 2026.

Its price-based Market X-Ray is 29 out of 100 (a weak price profile), ranking 234 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 14.9% and over the last three months it fell 7.5%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Nel ASA (NEL)

The five lenses in numbers each metric is ranked against the other stocks on Oslo Børs

Lens and metricValueScoreReading
Trend19 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-14.9%
From 52-week high-48.8%
Momentum27 · WeakLagging most stocks on this exchange.
3-month return-7.5%
6-month return-20.2%
12-month return, skipping the last month-11.1%
Stability (higher is calmer)22 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)59.0%
Worst drawdown, 1 year (smaller is calmer)-49.0%
Liquidity61 · FairModerate trading activity.
Average daily value traded4.87M NOK
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−1.7%
1 month−4.4%
3 months−7.5%
6 months−20.2%
1 year−14.9%
3 years−70.1%
5 years−87.7%

Signals

50-day / 200-day average2.062 / 2.314
Golden / death cross (60 days)Death, 55 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.072

Technical summary

DailyStrongly bearish2 bullish · 2 neutral · 12 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Børs; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026